Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Translated into:
Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Introduction to Weltinib Capsules
Weltinib Capsules are a trusted therapy for patients with chronic myeloid leukemia (CML), acute lymphoblastic leukemia (ALL), and certain types of gastrointestinal stromal tumors (GISTs). With Imatinib 100mg, this targeted treatment works by blocking cancer cell growth at its source, offering improved survival and quality of life.
Uses of Weltinib Capsules
Chronic myeloid leukemia (CML), particularly in the chronic phase
Acute lymphoblastic leukemia (ALL) with the Philadelphia chromosome
Gastrointestinal stromal tumors (GISTs) driven by KIT or PDGFRA mutations
Certain rare cancers and conditions linked to tyrosine kinase mutations
Benefits of Weltinib Capsules
Targeted cancer therapy that specifically blocks abnormal proteins
Proven effectiveness in managing chronic and acute leukemias
Improves survival and remission rates in CML and GISTs
Convenient once-daily dosing for long-term treatment compliance
Clinically tested for safety and efficacy in eligible patients
Mechanism of Action of Weltinib Capsules
Inhibits tyrosine kinase activity in cancer cells, reducing their ability to grow and divide.
Targets the BCR-ABL protein in CML, halting uncontrolled cell production.
Blocks KIT and PDGFRA mutations in GISTs, slowing tumor progression and shrinking existing growths.
Helps restore normal cell function and prevent disease progression.
For best results, take Weltinib Capsules as prescribed by your oncologist. Regular monitoring is essential to ensure the treatment is working effectively and to manage any side effects. Store in a cool, dry place and keep out of reach of children.